Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Soon-Hee | - |
dc.contributor.author | Seo, Misun | - |
dc.contributor.author | Hwang, Hongik | - |
dc.contributor.author | Moon, Dong-Min | - |
dc.contributor.author | Son, Gi Hoon | - |
dc.contributor.author | Kim, Kyungjin | - |
dc.contributor.author | Rhim, Hyewhon | - |
dc.date.accessioned | 2024-01-19T21:01:00Z | - |
dc.date.available | 2024-01-19T21:01:00Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 1226-2560 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/120402 | - |
dc.description.abstract | 5-HT6 receptor (5-HT6R) is implicated in cognitive dysfunction, mood disorder, psychosis, and eating disorders. However, despite its significant role in regulating the brain functions, regulation of 5-HT6R at the molecular level is poorly understood. Here, using yeast two-hybrid assay, we found that human 5-HT6R directly binds to neuro-oncological ventral antigen 1 (Nova-1), a brain-enriched splicing regulator. The interaction between 5-HT6R and Nova-1 was confirmed using GST pull-down and co-immunoprecipitation assays in cell lines and rat brain. The splicing activity of Nova-1 was decreased upon overexpression of 5-HT6R, which was examined by detecting the spliced intermediates of gonadotropin-releasing hormone (GnRH), a known pre-mRNA target of Nova-1, using RT-PCR. In addition, overexpression of 5-HT6R induced the translocation of Nova-1 from the nucleus to cytoplasm, resulting in the reduced splicing activity of Nova-1. In contrast, overexpression of Nova-1 reduced the activity and the total protein levels of 5-HT6R. Taken together, these results indicate that when the expression levels of 5-HT6R or Nova-1 protein are not properly regulated, it may also deteriorate the function of the other. | - |
dc.language | English | - |
dc.publisher | KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE | - |
dc.title | Physical and Functional Interaction between 5-HT6 Receptor and Nova-1 | - |
dc.type | Article | - |
dc.identifier.doi | 10.5607/en.2019.28.1.17 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Experimental Neurobiology, v.28, no.1, pp.17 - 29 | - |
dc.citation.title | Experimental Neurobiology | - |
dc.citation.volume | 28 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 17 | - |
dc.citation.endPage | 29 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.kciid | ART002444277 | - |
dc.identifier.wosid | 000460388900002 | - |
dc.identifier.scopusid | 2-s2.0-85067888899 | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | SB-399885 | - |
dc.subject.keywordPlus | ANTIGEN | - |
dc.subject.keywordPlus | RNA-BINDING PROTEINS | - |
dc.subject.keywordPlus | ANTAGONIST | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | MODELS | - |
dc.subject.keywordPlus | ANTIDEPRESSANT | - |
dc.subject.keywordPlus | LOCALIZATION | - |
dc.subject.keywordPlus | RECOGNITION | - |
dc.subject.keywordAuthor | Serotonin | - |
dc.subject.keywordAuthor | 5-HT6 receptor | - |
dc.subject.keywordAuthor | Neuro-oncological ventral antigen 1 | - |
dc.subject.keywordAuthor | RNA binding proteins | - |
dc.subject.keywordAuthor | Neurological diseases | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.